Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7952 results

Sort By:

AMT-116 in Patients With Advanced Solid Tumors

Study ID: NCT05725291
Start Date: 2023-07-25
End Date: 2025-07-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

80

Intervention / Treatment

AMT-116

Sponsor

Multitude Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

Study ID: NCT05766891
Start Date: 2023-10-12
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

225

Intervention / Treatment

Group 1

Group 2

Group 3

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM)

Study ID: NCT06055894
Start Date: 2023-09-20
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Omega-3

Curcumin

Probiotic

Whole food, plant-based diet (WFPBD)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Study ID: NCT06014762
Start Date: 2024-04-16
End Date: 2041-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

120

Intervention / Treatment

P-CD19CD20-ALLO1

Rimiducid

Sponsor

Poseida Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Study ID: NCT05849662
Start Date: 2024-10-11
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

58

Intervention / Treatment

Trametinib

Azacitidine

Fludarabine

Cytarabine

Sponsor

Therapeutic Advances in Childhood Leukemia Consortium

Source: clinicaltrials.gov

Share:
Add to list

Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.

Study ID: NCT04839991
Start Date: 2021-06-08
End Date: 2024-09-25
Study Type

Interventional

Study Phase

Phase1

No. of Participants

70

Intervention / Treatment

Seven 07

Sponsor

Crescendo Biologics Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors

Study ID: NCT06442891
Start Date: 2024-10-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Acupressure Therapy

Acupressure Therapy

Internet-Based Intervention

Interview

Medical Device Usage and Evaluation

Administration questionnaire

Sponsor

University of Michigan Rogel Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...

Study ID: NCT05621291
Start Date: 2025-05-12
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

NGS testing

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment

Study ID: NCT05889091
Start Date: 2023-05-16
End Date: 2026-05-16
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

HRQOL instruments

LENT SOMA instrument

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Study ID: NCT04754191
Start Date: 2022-02-03
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

Emportumab Vedotin

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list